What was the overall valuation of the US folliculitis market in 2024?

The overall market valuation was $417.9 Million in 2024. Read More

What is the projected market valuation for the US folliculitis market by 2035?

The projected valuation for 2035 is $841.53 Million. Read More

What is the expected CAGR for the US folliculitis market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 6.57%. Read More

What are the main types of folliculitis and their market valuations?

Bacterial Folliculitis was valued at $150.0 - $300.0 Million, Fungal Folliculitis at $100.0 - $200.0 Million, Viral Folliculitis at $50.0 - $100.0 Million, and Non-Infectious Folliculitis at $117.9 - $241.53 Million. Read More

What treatment methods are available for folliculitis and their market sizes?

Topical Antibiotics were valued at $83.68 - $169.36 Million, Oral Antibiotics at $62.85 - $128.57 Million, Antifungal Medications at $41.79 - $85.36 Million, Steroid Injections at $25.07 - $51.36 Million, and Laser Therapy at $204.51 - $406.88 Million. Read More

What are the end-user segments for the US folliculitis market?

End-user segments include Hospitals valued at $150.0 - $300.0 Million, Dermatology Clinics at $120.0 - $240.0 Million, and Home Care Settings at $147.9 - $301.53 Million. Read More

How is the distribution channel structured in the US folliculitis market?

Distribution channels include Pharmacies valued at $200.0 - $400.0 Million, Online Pharmacies at $150.0 - $300.0 Million, and Health and Wellness Stores at $67.9 - $141.53 Million. Read More

What factors may influence the growth of the US folliculitis market in the coming years?

Factors influencing growth may include advancements in treatment methods, increasing awareness of skin conditions, and the rising prevalence of folliculitis. Read More

How does the market for folliculitis compare across different treatment methods?

Laser Therapy appears to dominate the market with a valuation of $204.51 - $406.88 Million, followed by Topical Antibiotics and Oral Antibiotics. Read More

US Folliculitis Market

Q: Which companies are key players in the US folliculitis market?

Key players include Johnson & Johnson, GlaxoSmithKline, Bayer AG, Novartis AG, Pfizer Inc., Sanofi, AbbVie Inc., and Merck & Co., Inc. Read More

ID: MRFR/Pharma/18391-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Folliculitis Market Research Report By Type (Bacterial Folliculitis, Fungal Folliculitis, Viral Folliculitis, Non-Infectious Folliculitis), By Treatment Method (Topical Antibiotics, Oral Antibiotics, Antifungal Medications, Steroid Injections, Laser Therapy), By End User (Hospitals, Dermatology Clinics, Home Care Settings) and By Distribution Channel (Pharmacies, Online Pharmacies, Health and Wellness Stores) - Growth & Industry Forecast 2025 To 2035

US Folliculitis Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.57%

2024 Market Size$ 417.9 Million

2025 Market Size$ 445.36 Million

2035 Market Size$ 841.53 Million

Key Players

Johnson & Johnson

GlaxoSmithKline

Bayer AG

Novartis AG

Pfizer Inc.

Sanofi

Trends

Rising Consumer Awareness
Technological Integration in Treatments
Shift Towards Natural Ingredients

Opportunities

Increasing Incidence of Folliculitis
Rising Focus on Preventive Healthcare
Advancements in Dermatological Research

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Type (USD Million)
  1. 4.1.1 Bacterial Folliculitis
  2. 4.1.2 Fungal Folliculitis
  3. 4.1.3 Viral Folliculitis
  4. 4.1.4 Non-Infectious Folliculitis
2. 4.2 Chemicals and Materials, BY Treatment Method (USD Million)
  1. 4.2.1 Topical Antibiotics
  2. 4.2.2 Oral Antibiotics
  3. 4.2.3 Antifungal Medications
  4. 4.2.4 Steroid Injections
  5. 4.2.5 Laser Therapy
3. 4.3 Chemicals and Materials, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Dermatology Clinics
  3. 4.3.3 Home Care Settings
4. 4.4 Chemicals and Materials, BY Distribution Channel (USD Million)
  1. 4.4.1 Pharmacies
  2. 4.4.2 Online Pharmacies
  3. 4.4.3 Health and Wellness Stores
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Johnson & Johnson (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 GlaxoSmithKline (GB)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bayer AG (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Novartis AG (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Pfizer Inc. (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Sanofi (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 AbbVie Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Merck & Co., Inc. (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY TREATMENT METHOD
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY TREATMENT METHOD, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY TREATMENT METHOD, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT METHOD, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Type (USD Million, 2025-2035)

Bacterial Folliculitis
Fungal Folliculitis
Viral Folliculitis
Non-Infectious Folliculitis

Chemicals and Materials By Treatment Method (USD Million, 2025-2035)

Topical Antibiotics
Oral Antibiotics
Antifungal Medications
Steroid Injections
Laser Therapy

Chemicals and Materials By End User (USD Million, 2025-2035)

Hospitals
Dermatology Clinics
Home Care Settings

Chemicals and Materials By Distribution Channel (USD Million, 2025-2035)

Pharmacies
Online Pharmacies
Health and Wellness Stores

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”